Dr. FLAVIA Matovu

Dr. Flavia Matovu Kiweewa (MBChB, MSc. Epidemiology, PhD Public Health) is the Director of Research at the MU-JHU Research Collaboration and a lecturer with the Department of Epidemiology and Biostatistics at Makerere University School of Public Health in Kampala, Uganda. Her career, both as a clinician and researcher, has been dedicated to ensuring that HIV most at-risk women have access to high-quality treatment and prevention services. She is the Uganda National Principal Investigator for the Gilead Sponsored PURPOSE 1 study, a Phase 3 efficacy trial of Lenacapavir and DESCOVY® for PrEP in Adolescent Girls and Young Women, and PI on several other studies.

Her commitment to excellence in clinical and public health research is evident through substantial contributions, including grant awards from esteemed institutions such as the National Institutes of Health (NIH) and Gilead Sciences Inc. Notably, her work on bone health, stemming from her NIH R01 (BONE: CARE study), led to remarkable findings published in the Lancet Global Health in 2022, earning her the prestigious PhD award in 2021 from the University of Witwatersrand. Flavia is also the 2024 Phoebe Leboy Professional Development Award Recipient, an annual award by the American Society for Bone and Mineral Research in recognition of young women scientists residing outside the US. Outside her regular work, she serves on several scientific committees, provides on-going technical support to the Uganda Ministry of Health and has been involved in the development of the HIV treatment and PrEP guidelines.

Fun fact: She’s fueled by a great cup of African tea and regular exercise.